Diabetic dyslipidemia and atherosclerosis

Area of Science:

• Endocrinology
• Cardiovascular Medicine
• Metabolic Disorders

Background:

• Non-insulin-dependent diabetes mellitus (NIDDM) is associated with dyslipidemia.
• Common lipid abnormalities include elevated triglycerides and reduced high-density lipoprotein (HDL)-cholesterol.
• These lipid changes are established risk factors for coronary heart disease (CHD).

Purpose of the Study:

• To investigate the relationship between NIDDM and plasma lipid/lipoprotein abnormalities.
• To understand the role of altered lipoproteins in the atherogenic process in diabetes.
• To identify effective strategies for correcting dyslipidemia in diabetic patients.

Main Methods:

• Analysis of plasma lipid and lipoprotein profiles in patients with NIDDM.
• Assessment of the impact of triglyceride-rich lipoproteins on low-density lipoprotein (LDL) and HDL particle remodelling.
• Evaluation of interventions including glycemic control, diet, and fibrate therapy.

Main Results:

• NIDDM frequently presents with qualitative and quantitative abnormalities in plasma lipids and lipoproteins.
• Increased triglycerides and decreased HDL-cholesterol are common findings.
• Moderately elevated triglyceride-rich lipoproteins may influence LDL and HDL particle remodelling, contributing to atherosclerosis.

Conclusions:

• Dyslipidemia is a significant comorbidity of NIDDM, elevating cardiovascular risk.
• Improved glycemic control, dietary modifications, and pharmacotherapy (e.g., fibrates) can effectively manage and potentially reverse these lipoprotein abnormalities.
• Targeting lipid profiles is crucial for mitigating atherosclerosis in diabetic individuals.